v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Total net sales $ 880 $ 879
Cost of products sold 453 413
Gross profit 427 466
Selling, general, and administrative expenses 351 358
Research and development expenses 44 36
Restructuring and other costs 67 9
Operating (loss) income (35) 63
Other income and expenses:    
Interest expense, net 24 19
Other (income) expense, net (17) 0
Income before income taxes (42) 44
(Benefit) provision for income taxes (32) 25
Net (loss) income (10) 19
Less: Net loss attributable to noncontrolling interest 0 (1)
Net (loss) income attributable to Dentsply Sirona $ (10) $ 20
(Loss) earnings per common share attributable to Dentsply Sirona:    
Basic (in dollars per share) $ (0.05) $ 0.10
Diluted (in dollars per share) $ (0.05) $ 0.10
Weighted average common shares outstanding:    
Basic (in shares) 199.9 199.1
Diluted (in shares) 199.9 199.8